The adoption of automated inspection systems in the biotechnology and pharmaceutical sectors, as well as the rise in product recalls, the number of inspection checkpoints along the production line, and technical developments in inspection systems, all contribute to the market\'s expansion. Due to increased worries about the regulatory obligations set by the government and regulatory organisations in the healthcare industry to maintain compliance with Good Manufacturing Practices, businesses are increasingly employing inspection systems throughout their production lines (GMP).